Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: MisterED who wrote (639)	3/22/1998 10:31:00 AM
From: BigKNY3	Respond to of 9523

Mr Ed <<But one thing is for sure, Pfizer does not know either and they have proven over and over again that they are worried about Muse.>> Mr Ed ,I disagree with you. Nothing new! MUSE and Carvarject are not the competition for an oral ED product. The main competitor is lack of awareness for proper ED diagnosis and treatment from patients and physicians. Have PFun! BigKNY3

To: MisterED who wrote (639)	3/22/1998 11:15:00 AM
From: Jacques Tootight	Read Replies (1) \| Respond to of 9523

Mister Ed, I obviously failed to make my point. As an "investor",(and this is strictly my own style and philosophy, I'm not preaching to anyone) I am not at all concerned about Viagra v. Muse. I didn't invest in a one trick poney. I put my money into PFE for all the underlying reasons everybody else here did. It's just a great company with many great products and many more coming. As a leading edge baby boomer I and the hordes behind me will keep the drug companies flush with cash for the next twenty years. Viagra has the potential to add to what is already a good investment. If after a six months or a year the product is a bust or a competitor has developed something better so what. The cupboard is anything but bare. The upside potential is great, the downside won't hurt PFE all that significantly I think. On the other hand as a "trader" I'll play the Viagra news and anticipation for all its worth. Since Thursday my April calls have doubled and I'm looking for more this week. This news and anticipation will hopefully give the stock the momentum it needs to push past the resistance it had at $90. If the news is bad will there be a pull back? Sure. But short term I will have made a profit, and long term my investment will have moved forward to another level. I personally am not that concerned with the pros and cons of any particular new drug that comes along, only what it might do for my balance sheet. As my tech stocks continue to get beat down I sure can use a shot of Viagra. Thanks for listening - rc